Best TWAS P=2.02e-09 · Best GWAS P=1.81e-08 conditioned to 0.804
# | Study | Tissue | Gene | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | GTEx | Adrenal Gland | AP3S2 | 0.37 | 0.14 | lasso | 7 | 0.11 | 1.1e-04 | 5.6 | 5.5 | 3.3e-08 | 0.95 | 0.01 | 0.99 | FALSE |
2 | GTEx | Cells Transformed fibroblasts | AP3S2 | 0.22 | 0.16 | lasso | 5 | 0.18 | 4.1e-13 | 5.5 | 5.5 | 5.0e-08 | 0.96 | 0.01 | 0.99 | FALSE |
3 | GTEx | Esophagus Mucosa | AP3S2 | 0.19 | 0.16 | lasso | 1 | 0.15 | 4.0e-10 | 5.4 | 5.4 | 5.5e-08 | 0.94 | 0.01 | 0.99 | FALSE |
4 | GTEx | Whole Blood | AP3S2 | 0.19 | 0.06 | lasso | 2 | 0.09 | 2.8e-08 | 5.4 | 5.8 | 6.0e-09 | 0.90 | 0.01 | 0.99 | FALSE |
5 | NTR | Blood | AP3S2 | 0.17 | 0.11 | enet | 26 | 0.14 | 2.7e-43 | 5.4 | 5.5 | 3.4e-08 | 0.90 | 0.01 | 0.99 | FALSE |
6 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | ANPEP | 0.07 | 0.03 | enet | 4 | 0.02 | 9.1e-03 | -5.4 | 5.2 | 1.6e-07 | 0.50 | 0.01 | 0.85 | FALSE |
7 | The Cancer Genome Atlas | Bladder Urothelial Carcinoma | AP3S2 | 0.19 | 0.27 | lasso | 4 | 0.24 | 2.0e-20 | 5.6 | 5.6 | 2.0e-08 | 1.00 | 0.00 | 1.00 | FALSE |
8 | The Cancer Genome Atlas | Breast Invasive Carcinoma | AP3S2 | 0.13 | 0.19 | lasso | 5 | 0.20 | 5.3e-40 | 5.5 | 5.6 | 2.6e-08 | 0.97 | 0.01 | 0.99 | FALSE |
9 | The Cancer Genome Atlas | Cervical Squamous Cell Carcinoma | AP3S2 | 0.23 | 0.27 | lasso | 1 | 0.26 | 3.8e-13 | 5.5 | 5.5 | 3.0e-08 | 0.93 | 0.01 | 0.99 | FALSE |
10 | The Cancer Genome Atlas | Colon Adenocarcinoma | AP3S2 | 0.18 | 0.18 | lasso | 4 | 0.17 | 5.2e-10 | 5.5 | 6.0 | 2.0e-09 | 0.92 | 0.01 | 0.99 | TRUE |
11 | The Cancer Genome Atlas | Esophageal Carcinoma | AP3S2 | 0.22 | 0.15 | lasso | 2 | 0.13 | 6.2e-05 | 5.5 | 5.5 | 2.9e-08 | 0.94 | 0.01 | 0.98 | FALSE |
12 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | AP3S2 | 0.15 | 0.24 | enet | 14 | 0.27 | 6.3e-30 | 5.5 | 5.3 | 1.3e-07 | 0.95 | 0.01 | 0.99 | FALSE |
13 | The Cancer Genome Atlas | Head and Neck Squamous Cell Carcinoma | C15orf38 | 0.02 | 0.03 | lasso | 1 | 0.02 | 1.9e-03 | 5.5 | -5.5 | 4.4e-08 | -0.95 | 0.00 | 0.95 | FALSE |
14 | The Cancer Genome Atlas | Kidney Renal Clear Cell Carcinoma | AP3S2 | 0.27 | 0.38 | lasso | 4 | 0.39 | 3.1e-47 | 5.4 | 5.5 | 3.6e-08 | 0.97 | 0.02 | 0.98 | FALSE |
15 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | ANPEP | 0.15 | 0.05 | blup | 55 | 0.07 | 5.6e-05 | -5.5 | -5.5 | 3.9e-08 | -0.81 | 0.01 | 0.93 | FALSE |
16 | The Cancer Genome Atlas | Kidney Renal Papillary Cell Carcinoma | AP3S2 | 0.28 | 0.28 | blup | 61 | 0.33 | 1.5e-19 | 5.4 | 5.3 | 1.5e-07 | 0.92 | 0.01 | 0.99 | FALSE |
17 | The Cancer Genome Atlas | Brain Lower Grade Glioma | AP3S2 | 0.23 | 0.27 | lasso | 6 | 0.30 | 3.2e-34 | 5.5 | 5.6 | 1.7e-08 | 0.96 | 0.01 | 0.99 | FALSE |
18 | The Cancer Genome Atlas | Liver Hepatocellular Carcinoma | AP3S2 | 0.27 | 0.22 | lasso | 5 | 0.23 | 3.0e-11 | 5.4 | 5.5 | 3.6e-08 | 0.96 | 0.01 | 0.99 | FALSE |
19 | The Cancer Genome Atlas | Lung Adenocarcinoma | AP3S2 | 0.22 | 0.38 | lasso | 4 | 0.39 | 2.3e-48 | 5.5 | 5.6 | 2.6e-08 | 0.97 | 0.01 | 0.99 | FALSE |
20 | The Cancer Genome Atlas | Lung Squamous Cell Carcinoma | AP3S2 | 0.22 | 0.26 | enet | 18 | 0.30 | 1.6e-34 | 5.5 | 5.6 | 2.1e-08 | 0.95 | 0.01 | 0.99 | FALSE |
21 | The Cancer Genome Atlas | Ovarian Serous Cystadenocarcinoma | AP3S2 | 0.15 | 0.14 | blup | 62 | 0.15 | 1.8e-10 | 5.6 | 5.4 | 8.5e-08 | 0.92 | 0.01 | 0.99 | FALSE |
22 | The Cancer Genome Atlas | Pancreatic Adenocarcinoma | AP3S2 | 0.44 | 0.37 | lasso | 3 | 0.39 | 2.2e-17 | 5.4 | 5.5 | 3.3e-08 | 0.97 | 0.01 | 0.99 | FALSE |
23 | The Cancer Genome Atlas | Pheochromocytoma and Paraganglioma | AP3S2 | 0.41 | 0.45 | lasso | 6 | 0.44 | 4.0e-19 | 5.5 | 5.6 | 2.5e-08 | 0.97 | 0.01 | 0.99 | FALSE |
24 | The Cancer Genome Atlas | Prostate Adenocarcinoma | AP3S2 | 0.44 | 0.54 | enet | 13 | 0.55 | 3.3e-68 | 5.5 | 5.4 | 5.8e-08 | 0.97 | 0.01 | 0.99 | FALSE |
25 | The Cancer Genome Atlas | Rectum Adenocarcinoma | AP3S2 | 0.18 | 0.19 | lasso | 5 | 0.15 | 2.1e-04 | 5.5 | 5.6 | 2.6e-08 | 0.97 | 0.01 | 0.88 | FALSE |
26 | The Cancer Genome Atlas | Soft Tissue Sarcoma | AP3S2 | 0.14 | 0.18 | enet | 5 | 0.16 | 1.2e-09 | 5.4 | 5.6 | 2.5e-08 | 0.97 | 0.01 | 0.99 | FALSE |
27 | The Cancer Genome Atlas | Skin Cutaneous Melanoma | AP3S2 | 0.19 | 0.09 | lasso | 2 | 0.04 | 2.7e-02 | 5.5 | 5.5 | 4.7e-08 | 0.97 | 0.01 | 0.85 | FALSE |
28 | The Cancer Genome Atlas | Stomach Adenocarcinoma | AP3S2 | 0.13 | 0.16 | lasso | 2 | 0.17 | 2.6e-12 | 5.4 | 5.6 | 2.2e-08 | 0.98 | 0.01 | 0.99 | FALSE |
29 | The Cancer Genome Atlas | Testicular Germ Cell Tumors | AP3S2 | 0.29 | 0.32 | blup | 59 | 0.32 | 8.2e-12 | 5.5 | 5.7 | 1.6e-08 | 0.91 | 0.01 | 0.99 | FALSE |
30 | The Cancer Genome Atlas | Thyroid Carcinoma | AP3S2 | 0.30 | 0.45 | lasso | 7 | 0.44 | 7.0e-47 | 5.4 | 5.7 | 1.2e-08 | 0.97 | 0.01 | 0.99 | FALSE |
31 | The Cancer Genome Atlas | Uterine Corpus Endometrial Carcinoma | AP3S2 | 0.26 | 0.25 | lasso | 4 | 0.25 | 1.4e-07 | 5.5 | 5.6 | 2.0e-08 | 0.96 | 0.01 | 0.99 | FALSE |